Hannah Bader

Title: The Innovative Contributions of Hannah Bader

Introduction

Hannah Bader is a prominent inventor based in Waltham, MA (US). She has made significant strides in the field of cancer immunotherapy, holding 2 patents that showcase her innovative approach to combating cancer. Her work focuses on developing novel therapeutic strategies that enhance the immune response against tumors.

Latest Patents

One of her latest patents involves anti-PD-L1 cancer immunotherapy antibodies. This patent provides compositions and methods related to fully human antibodies that bind to PD-L1, along with their fragments and derivatives. These antibodies are designed to exhibit antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) activities, which are crucial for effective cancer treatment. Another significant patent is for rationally designed protein compositions. This invention combines a therapeutic antibody with an IL2 mutant, aiming to enhance anti-tumor immunity while simultaneously activating effector cells without triggering T-cell activation. This fusion protein has the potential to prevent or therapeutically treat cancer.

Career Highlights

Hannah has worked with notable companies such as 1Globe Biomedical and 1Globe Health Institute LLC. Her experience in these organizations has contributed to her expertise in the field of biomedical research and innovation.

Collaborations

Throughout her career, Hannah has collaborated with talented individuals, including Chiang Jia Li and Shyam Unniraman. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in cancer research.

Conclusion

Hannah Bader's contributions to cancer immunotherapy through her innovative patents and collaborations highlight her role as a leading inventor in the field. Her work continues to pave the way for new therapeutic strategies that could significantly impact cancer treatment.